Heranba posts tax-aided consolidated profit as pre-tax loss returns, revenue -29% YoY
revenue -28.68% · margins compressing
₹372.09 Cr
-28.68% YoY
₹2.64 Cr
0.71%
+1.1pp YoY
₹0.76
Heranba Industries' consolidated PAT for Q2 FY27 (quarter ended September 30, 2026) was ₹2.64 Cr, nominally a turnaround from a ₹2.14 Cr net loss in Q2 FY26 (a reported swing of roughly +223%), but down 62% QoQ from ₹7.03 Cr in Q1 FY27. That headline improvement is not operational: consolidated profit before tax was itself a LOSS of ₹1.50 Cr this quarter, versus a PBT profit of ₹7.74 Cr a year ago and ₹20.10 Cr last quarter. The swing into net profit came from a ₹10.99 Cr deferred tax credit that more than offset a ₹6.85 Cr current-tax charge, producing a net tax credit of ₹4.14 Cr for the quarter. Stripping out that one-off credit, adjusted PAT would have been a loss of roughly ₹8.35 Cr — a deepening of losses versus the ₹2.14 Cr loss a year ago (adjusted PAT YoY change of about -290%), the opposite of the reported "turnaround" headline. Revenue fell 28.7% YoY and 3.1% QoQ to ₹372.09 Cr, driven by a 41.9% YoY drop in exports (₹140.67 Cr to ₹81.79 Cr) and a 23.8% YoY decline domestically (₹381.04 Cr to ₹290.30 Cr).
Q2 FY-2027 vs prior quarters
Operating margin (EBITDA/revenue) compressed to roughly 8.6% from about 9.4% a year ago and 13.0% last quarter, as cost of materials and traded-goods purchases stayed elevated relative to the smaller revenue base. Net margin nominally improved to 0.71% from -0.41% YoY but trails Q1 FY27's 1.83%, and as above the YoY improvement is a tax artifact rather than an operating one. Standalone (secondary basis) results paint a rosier but misleading picture if read in isolation: standalone PAT was ₹27.09 Cr — more than ten times the consolidated figure — down 15.4% YoY on a 45.1% revenue decline to ₹332.59 Cr. The gap is driven by ₹19.80 Cr of standalone-only other income (versus just ₹0.03 Cr at the consolidated level, largely intercompany dividend/interest income eliminated on consolidation) and continuing drag from the group's subsidiaries (Mikusu India, Heranba Organics, Daikaffil Chemicals India and Mikusu Global). This standalone-consolidated divergence is unusually wide, and the consolidated figure — not the standalone one — is the number that reflects the group's actual quarter.
The stock went into the print at ₹150.74, down 11.2% over the past month of trading.
Management has no formal guidance on record for this business, and this filing's board-outcome letter carries no further commentary on the quarter's drivers, so there is nothing from management to grade the print against beyond the raw numbers; a web search found no analyst consensus estimates specific to Q2 FY27 for Heranba, consistent with the stock's limited analyst coverage. The results land alongside a leadership change: the company's CFO resigned (announced October 26, 2026) and the board has appointed Rajib Mukhopadhyay as the new CFO, effective January 1, 2027 — a transition landing in the same cycle as a quarter where profitability depended on a tax credit rather than operations.
W1
Whether the group posts a genuine pre-tax profit next quarter, given Q2 FY27's ₹1.50 Cr pre-tax loss was only offset by a ₹10.99 Cr deferred tax credit that may not recur
W2
Export revenue trajectory — down 41.9% YoY to ₹81.79 Cr this quarter — since it drove most of the topline decline
W3
New CFO Rajib Mukhopadhyay takes charge January 1, 2027; watch for any formal guidance or commentary introduced under the new finance leadership